Afuco™ Anti-S. epidermidis LTA ADCC Recombinant Antibody (Pagibaximab), ADCC Enhanced (CAT#: AFC-TAB-H53)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Chimeric (human/mouse) antibody to S. epidermidis LTA. Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Host Species
  • Chimeric
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • ADCC enhanced antibody
  • Specificity
  • Staphylococcus epidermidis lipoteichoic acid [Staphylococcus epidermidis]
  • Species Reactivity
  • S. epidermidis
  • Clone
  • Pagibaximab
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP
  • Conjugate
  • Unconjugated
  • Generic Name
  • Pagibaximab
  • Related Disease
  • Staphylococcal sepsis in infants with low birth weight

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Pagibaximab; 595566-61-3; BSYX-A110; A110; HU96-110; Lipoteichoic acid; LTA; S. epidermidis LTA; Staphylococcus epidermidis lipoteichoic acid

Related Resources

  • Biosimilar Overview
Please refer to Pagibaximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Pagibaximab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "pagibaximab"

Anti-S. Epidermidis LTA Recombinant Antibody (Pagibaximab)
Recombinant Chimeric (human/mouse) antibody to S. epidermidis LTA. Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.

See other products for "S. epidermidis LTA"

Chimeric Antibody

CAT Product Name Application Type
TAB-H53 Anti-S. Epidermidis LTA Recombinant Antibody (Pagibaximab) ELISA IgG1 - kappa

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-H53. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare